Diagnamed Holdings Corp.

OTCPK:DGNM.F Stock Report

Market Cap: US$1.4m

Diagnamed Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:DGNM.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Nov 24BuyUS$586Fabio ChianelliIndividual55,000US$0.011
25 Nov 24BuyUS$536Fabio ChianelliIndividual50,000US$0.011
22 Nov 24BuyUS$651Fabio ChianelliIndividual45,530US$0.014
22 Nov 24BuyUS$715Fabiotech Inc.Company50,000US$0.014
01 Nov 24BuyUS$377Fabio ChianelliIndividual21,000US$0.018
01 Nov 24BuyUS$1,077Fabio ChianelliIndividual50,000US$0.022
01 Nov 24BuyUS$72Fabio ChianelliIndividual4,000US$0.018
30 Oct 24BuyUS$1,437Fabio ChianelliIndividual100,000US$0.014
17 Sep 24BuyUS$463Fabio ChianelliIndividual126,000US$0.0037
01 Aug 24BuyUS$657Fabio ChianelliIndividual91,000US$0.0072
04 Jul 24BuyUS$588Fabio ChianelliIndividual40,000US$0.015
25 Apr 24BuyUS$328Fabio ChianelliIndividual10,000US$0.033
11 Apr 24BuyUS$1,640Fabio ChianelliIndividual75,000US$0.022
18 Mar 24BuyUS$487Fabio ChianelliIndividual10,000US$0.049
11 Mar 24BuyUS$580Fabio ChianelliIndividual22,330US$0.026
04 Mar 24BuyUS$442Fabio ChianelliIndividual20,000US$0.022
28 Feb 24BuyUS$221Fabio ChianelliIndividual10,000US$0.022
28 Feb 24BuyUS$258Fabiotech Inc.Company10,000US$0.026
28 Feb 24BuyUS$66Fabio ChianelliIndividual3,000US$0.022

Insider Trading Volume

Insider Buying: DGNM.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DGNM.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,844,1779.8%
Individual Insiders9,949,17712.4%
General Public62,259,28677.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 3 shareholders own 22.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.93%
Fabio Chianelli
7,949,177US$139.2k4.27%no data
9.8%
Fabiotech Inc.
7,844,177US$137.3k4,030%no data
2.5%
Carlo Sansalone
2,000,000US$35.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 10:59
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Diagnamed Holdings Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.